Stockreport

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]

Aligos Therapeutics, Inc. - Common stock  (ALGS) 
PDF clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today reported recent business p [Read more]